These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 94498)

  • 41. Metabolism of [3H]-methylcholanthrene in the perfused rat liver.
    Takahashi G; Shah H; Weinhouse S
    Cancer Res; 1977 Feb; 37(2):369-75. PubMed ID: 188544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased biliary excretion of thyroxine by microsomal enzyme inducers.
    Vansell NR; Klaassen CD
    Toxicol Appl Pharmacol; 2001 Nov; 176(3):187-94. PubMed ID: 11714251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of oral diazepam pretreatment on the biliary excretion of sulfobromophthalein in rats.
    Hanasono GK; de Repentigny L; Priestly BG; Plaa GL
    Can J Physiol Pharmacol; 1976 Aug; 54(4):603-12. PubMed ID: 974887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of glutathione in the biliary excretion of the arsenical drugs trimelarsan and melarsoprol.
    Gregus Z; Gyurasics A
    Biochem Pharmacol; 2000 Jun; 59(11):1375-85. PubMed ID: 10751546
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mirex-induced impairment of hepatobiliary function. Suppressed biliary excretion of imipramine and sulfobromophthalein.
    Mehendale HM
    Drug Metab Dispos; 1977; 5(1):56-62. PubMed ID: 13976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of sodium taurocholate on the hepatic metabolism of sulfobromophthalein sodium (BSP). The role of bile flow.
    Boyer JL; Scheig RL; Klatskin G
    J Clin Invest; 1970 Feb; 49(2):206-15. PubMed ID: 5411780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biliary excretion of conjugated sulfobromophthalein (BSP) in constitutional conjugated hyperbilirubinemias.
    Abe H; Okuda K
    Digestion; 1975; 13(5):272-83. PubMed ID: 1205014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of ligandin as a binding protein and as an enzyme in the biliary excretion of sulfobromophthalein.
    Gregus Z; Klaassen CD
    J Pharmacol Exp Ther; 1982 Apr; 221(1):242-6. PubMed ID: 7062286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impairment of hepatic glutathione S-transferase activity as a cause of reduced biliary sulfobromophthalein excretion in clofibrate-treated rats.
    Foliot A; Touchard D; Celier C
    Biochem Pharmacol; 1984 Sep; 33(18):2829-34. PubMed ID: 6477642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biliary excretion of sulfobromophthalein compounds in normal and mutant Corriedale sheep. Evidence for a disproportionate transport defect for conjugated sulfobromophthalein.
    Barnhart JL; Gronwall RR; Combes B
    Hepatology; 1981; 1(5):441-7. PubMed ID: 7308989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impairment of sulfobromophthalein biliary excretion and inhibition of glutathione S-transferase activity induced by perhexiline maleate in rats.
    Mariscal MA; Muñoz ME; Collado PS; Esteller A; Gonzalez J
    Biochem Pharmacol; 1988 Sep; 37(18):3461-5. PubMed ID: 3421996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatocytes of Zones 1 and 3 conjugate sulfobromophthalein with glutathione.
    Chen EH; Gumucio JJ; Ho NH; Gumucio DL
    Hepatology; 1984; 4(3):467-76. PubMed ID: 6724515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maximal biliary transport of sulfobromophthalein in patients with a T-tube placed in the common bile duct.
    Serra MA; Caballero A; Del Olmo JA; Aparisi L; Gilabert MS; Rodríguez F; Escudero A; Wassel A; Ferrando J; Reig G; Rodrigo JM
    Eur J Drug Metab Pharmacokinet; 1997; 22(2):135-9. PubMed ID: 9248781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glutathione-dependent biliary excretion of arsenic.
    Gyurasics A; Varga F; Gregus Z
    Biochem Pharmacol; 1991 Jul; 42(3):465-8. PubMed ID: 1859460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of dehydrocholate sodium on the biliary reabsorption of sulfobromophtalein sodium from the rat biliary tree after retrograde intrabilary injection.
    Dammann HG; Süssenbach J; Czok G
    Klin Wochenschr; 1976 Aug; 54(16):789-91. PubMed ID: 957600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of diethylmaleate on the biliary excretion of infused sulphobromophthalein sodium and its glutathione conjugate in guinea-pigs.
    Whelan G
    Clin Exp Pharmacol Physiol; 1980 Nov; 7(6):595-601. PubMed ID: 7249400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulfobromophthalein inhibition of glutathione and methylmercury secretion into bile.
    Ballatori N; Clarkson TW
    Am J Physiol; 1985 Feb; 248(2 Pt 1):G238-45. PubMed ID: 3970204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biliary excretion of bromsulphthalein and glutathione conjugate of bromsulphthalein in rats pretreated with diethyl maleate.
    Varga F; Fischer E; Szily TS
    Biochem Pharmacol; 1974 Sep; 23(18):2617-23. PubMed ID: 4412194
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of arsenicals on biliary excretion of endogenous glutathione and xenobiotics with glutathione-dependent hepatobiliary transport.
    Gyurasics A; Varga F; Gregus Z
    Biochem Pharmacol; 1991 Mar 15-Apr 1; 41(6-7):937-44. PubMed ID: 2009085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of diethyl maleate on the biliary excretion rate of infused sulfobromophthalein-glutathione.
    Combes B; Backof B
    Biochem Pharmacol; 1982 Aug; 31(16):2669-74. PubMed ID: 7138560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.